Biology subjects

Lloyd-Jones, L. R.

Publications and source records attributed to Lloyd-Jones, L. R..

3 recordsLinked to original sources

bioRxiv2019

Bayesian analysis of GWAS summary data reveals differential signatures of natural selection across human complex traits and functional genomic categories

Understanding how natural selection has shaped the genetic architecture of complex traits and diseases is of importance in medical and evolutionary genetics. Bayesian methods have been developed using individual-level data to estimate multiple features of genetic architecture, including signatures of natural selection. Here, we present an enhanced method (SBayesS) that only requires GWAS summary statistics and incorporates functional genomic annotations. We analysed GWAS data with large sample sizes for 155 complex traits and detected pervasive signatures of negative selection with diverse estimates of SNP-based heritability and polygenicity. Projecting these estimates onto a map of genetic architecture obtained from evolutionary simulations revealed relatively strong natural selection on genetic variants associated with cardiorespiratory and cognitive traits and relatively small number of mutational targets for diseases. Averaging across traits, the joint distribution of SNP effect size and MAF varied across functional genomic regions (likely to be a consequence of natural selection), with enrichment in both the number of associated variants and the magnitude of effect sizes in regions such as transcriptional start sites, coding regions and 5- and 3-UTRs.

genetics↗

bioRxiv2019

Improved polygenic prediction by Bayesian multiple regression on summary statistics

The capacity to accurately predict an individuals phenotype from their DNA sequence is one of the great promises of genomics and precision medicine. Recently, Bayesian methods for generating polygenic predictors have been successfully applied in human genomics but require the individual level data, which are often limited in their access due to privacy or logistical concerns, and are computationally very intensive. This has motivated methodological frameworks that utilise publicly available genome-wide association studies (GWAS) summary data, which now for some traits include results from greater than a million individuals. In this study, we extend the established summary statistics methodological framework to include a class of point-normal mixture prior Bayesian regression models, which have been shown to generate optimal genetic predictions and can perform heritability estimation, variant mapping and estimate the distribution of the genetic effects. In a wide range of simulations and cross-validation using 10 real quantitative traits and 1.1 million variants on 350,000 individuals from the UK Biobank (UKB), we establish that our summary based method, SBayesR, performs similarly to methods that use the individual level data and outperforms other state-of-the-art summary statistics methods in terms of prediction accuracy and heritability estimation at a fraction of the computational resources. We generate polygenic predictors for body mass index and height in two independent data sets and show that by exploiting summary statistics on 1.1 million variants from the largest GWAS meta-analysis (n {approx} 700, 000) that the SBayesR prediction R2 improved on average across traits by 6.8% relative to that estimated from an individual-level data BayesR analysis of data from the UKB (n {approx} 450, 000). Compared with commonly used state-of-the-art summary-based methods, SBayesR improved the prediction R2 by 4.1% relative to LDpred and by 28.7% relative to clumping and p-value thresholding. SBayesR gave comparable prediction accuracy to the recent RSS method, which has a similar model, but at a computational time that is two orders of magnitude smaller. The methodology is implemented in a very efficient and user-friendly software tool titled GCTB.

genetics↗

bioRxiv2018

Novel susceptibility loci and genetic regulation mechanisms for type 2 diabetes

We conducted a meta-analysis of genome-wide association studies (GWAS) with [~]16 million genotyped/imputed genetic variants in 62,892 type 2 diabetes (T2D) cases and 596,424 controls of European ancestry. We identified 139 common and 4 rare (minor allele frequency < 0.01) variants associated with T2D, 42 of which (39 common and 3 rare variants) were independent of the known variants. Integration of the gene expression data from blood (n = 14,115 and 2,765) and other T2D-relevant tissues (n = up to 385) with the GWAS results identified 33 putative functional genes for T2D, three of which were targeted by approved drugs. A further integration of DNA methylation (n = 1,980) and epigenomic annotations data highlighted three putative T2D genes (CAMK1D, TP53INP1 and ATP5G1) with plausible regulatory mechanisms whereby a genetic variant exerts an effect on T2D through epigenetic regulation of gene expression. We further found evidence that the T2D-associated loci have been under purifying selection.

genetics↗